ConductScience.org, home

Paper40298389

Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies.

Koh K and 8 others. Cancer Discov, 2025. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies. Papers, record 40298389. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40298389

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies.
PubMed
Journal
Cancer Discov
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
4.44, provisional
iCite
Revised in PubMed
2026-10-23
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CachexiaMajor topic
NeoplasmsMajor topic
Humans
Quality of Life
Animals

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
OT2 CA278690NCI NIH HHSUnited StatesOT2CA278690PubMed and NIHNIH RePORTER
OT2 CA278701NCI NIH HHSUnited StatesOT2CA278701PubMed and NIHNIH RePORTER
P30 CA045508NCI NIH HHSUnited StatesP30CA045508PubMedNIH RePORTER

Download CSV of grants

References314

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120013699[Leptin serum levels in cachectic and non-cachectic lung cancer patients].Pneumonol Alergol Pol2009https://conductscience.org/library/papers/20013699PubMed
228094194MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study.Lancet Oncol2017https://conductscience.org/library/papers/28094194PubMed
338738581Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series.J Cachexia Sarcopenia Muscle2024https://conductscience.org/library/papers/38738581PubMed
437046095The evolution of non-small cell lung cancer metastases in TRACERx.Nature2023https://conductscience.org/library/papers/37046095PubMed
52582730Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer.Clin Physiol1989https://conductscience.org/library/papers/2582730PubMed
616186396Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.Diabetes2005https://conductscience.org/library/papers/16186396PubMed
719647909Resting energy expenditure and body composition in patients with newly detected cancer.Clin Nutr2010https://conductscience.org/library/papers/19647909PubMed
84828442Lactate inhibition of lipolysis in exercising man.Metabolism1974https://conductscience.org/library/papers/4828442PubMed
933137293Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.Lancet Diabetes Endocrinol2020https://conductscience.org/library/papers/33137293PubMed
1025043053Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia.Nature2014https://conductscience.org/library/papers/25043053PubMed
1131390573Modeling Human Cancer-induced Cachexia.Cell Rep2019https://conductscience.org/library/papers/31390573PubMed
1227030813Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients.J Cachexia Sarcopenia Muscle2016https://conductscience.org/library/papers/27030813PubMed
139392477Tumor necrosis factor-alpha induces apoptosis of human adipose cells.Diabetes1997https://conductscience.org/library/papers/9392477PubMed
1426903572Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer.J Clin Oncol2016https://conductscience.org/library/papers/26903572PubMed
1527829137Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.Cell Metab2016https://conductscience.org/library/papers/27829137PubMed
1634187898Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34187898PubMed
1736860137Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia.J Cachexia Sarcopenia Muscle2023https://conductscience.org/library/papers/36860137PubMed
1825560696Network of hypothalamic neurons that control appetite.BMB Rep2015https://conductscience.org/library/papers/25560696PubMed
1939510253Are Lean Body Mass and Fat-Free Mass the Same or Different Body Components? A Critical Perspective.Adv Nutr2024https://conductscience.org/library/papers/39510253PubMed
2031999069Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.J Cachexia Sarcopenia Muscle2020https://conductscience.org/library/papers/31999069PubMed

See all 314 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42926650Behavioral dysfunction but not wasting in cancer cachexia is driven by altered tryptophan metabolism.bioRxiv2026https://conductscience.org/library/papers/42926650PubMed
42869996Characterizing the onset and progression of cancer cachexia using routine clinical data.Nat Med2026https://conductscience.org/library/papers/42869996PubMed
42864412A health-system-scale, episode-resolved multimodal atlas of cancer cachexia.Nat Med2026https://conductscience.org/library/papers/42864412PubMed
42823780Metastatic Bone Disease Is Associated With Longitudinal Muscle Loss and Reduced Survival in Kidney Cancer.J Cachexia Sarcopenia Muscle2026https://conductscience.org/library/papers/42823780PubMed
42778549Heterogeneity in cancer: molecular mechanisms and therapeutic strategies.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42778549PubMed
42774252Risk factors for drug-related cachexia: an analysis based on the FDA adverse event reporting system (FAERS) from 2004 to 2025.Front Pharmacol2026https://conductscience.org/library/papers/42774252PubMed
42711451Reflecting on 25 years of cancer research: transformative advances and unmet expectations.Nat Rev Cancer2026https://conductscience.org/library/papers/42711451PubMed
42563007Pre-therapeutic prediction of cachexia in lymphoma patients using [18F]FDG PET radiomics of muscle and fat.Eur J Clin Nutr2026https://conductscience.org/library/papers/42563007PubMed
42508405Therapeutic Gfral silencing via antisense oligonucleotides ameliorates cancer-associated cachexia and extends survival in tumor-bearing mice.Cell Rep Med2026https://conductscience.org/library/papers/42508405PubMed
42417089Cancer cachexia: a caregiver and advocate perspective.Curr Opin Support Palliat Care2026https://conductscience.org/library/papers/42417089PubMed
42231158Microbiome and metabolome patterns centered on cancer cachexia link skeletal muscle and adipose tissue depletion to clinical outcomes in locally advanced rectal cancer.BMC Microbiol2026https://conductscience.org/library/papers/42231158PubMed
42117587Dietary supplementation with ursolic acid preserves skeletal muscle mass and strength in mouse models of cancer cachexia.Am J Physiol Cell Physiol2026https://conductscience.org/library/papers/42117587PubMed
41816244The pectoralis major index: a novel computed tomography biomarker for low thoracic muscle mass and eastern cooperative oncology group performance status in lung cancer patients.Front Nutr2026https://conductscience.org/library/papers/41816244PubMed
41749907Circulating Inflammatory and Mitochondrial Biomarkers Associated with Cachexia in Advanced Non-Small Cell Lung Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/41749907PubMed
41681974Sarcopenia in Older Adults with Hematologic Malignancies: A Comprehensive Review of Epidemiology, Prognosis, and Interventions.Cancers (Basel)2026https://conductscience.org/library/papers/41681974PubMed
41313474Treatment barriers among patients with cancer cachexia.Support Care Cancer2025https://conductscience.org/library/papers/41313474PubMed
41219223Reframing cancer cachexia: the vagal brain-liver axis as a novel neuro-metabolic target.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41219223PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40298389

GET https://conductscience.org/api/papers/v1/40298389/references?page=2